Patients with systemic breast cancer require aggressive therapeutic intervention and despite treatment, these patients often have a poor prognosis. Estrogen is known to play an important role in promoting breast progression from primary cancer to metastatic disease. How estrogen talks to breast cancer cells and a new potential target for a breast cancer treatment will be revealed in this talk.
Hilary Gaudet, Visiting Assistant Professor of Chemistry will present the next Faculty Lunch talk. Please join us on:
Thursday, October 8, 2015
12:30 – 1:30 pm